Boufenzer Amir
RESEARCH ENGINEER
Biopharmaceutical
INOTREM
France
Biography
After completing successfully a Master degree in Biochemistry and Molecular Biology, Amir Boufenzer joined the team of Pr Sebastien Gibot and Dr Marc Derive in 2010 to work on TREM-1 and its implication in the pathophysiology of cardiovascular diseases. After he obtained his PhD, Dr Amir Boufenzer joined the INOTREM team as Research Engineer in 2013. Amir’s work led to 2 patents presently licensed in INOTREM.
Research Interest
Pathophysiology of cardiovascular diseases
